タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
We have demonstrated that placental protein (PP 5) first detected by Bohn (1972) shows the same inhibitory effect on platelet aggregation as found in the isolation process of human placental extracts by our previous report. In this report, coagulation and fibrinolytic activities on placental platelet aggregation inhibitor (PPAI) and placental protein (PP 5) were examined. Materials and Methods: The microsomal fraction with an inhibitory effect of platelet aggregation was obteined from human placental extracts. The supernatant fraction concentrated by a column of Bio-beads SM-2 was isolated by gelfiltration on Sephadex G-150 or G-100. PP 5 was measured by RIA using a double antibody method. Antiplasmin and placental UK inhibitor (Kawano) activities were assayed by the chromogenic substrates, S-2251 and S-2444, respectively. Results: 1) PPAI consists of two types of proteins with molecular weights of 78, 000 and 112, 000. 2) Although PPAI appeared relatively the shortened clotting time, it showed neither antiplasmin activity nor UK inhibitory effect. 3) PP 5 had relatively prolonged APTT and thrombin time, but it was found to inhibit the activity of plasmin. 4) Although PP 5 showed no UK inhibitory activity, it was detectable that PP5 is mixed into the placental UK inhibitor (Kawano) by SDS-PAGE method.In conclusion, it is suggested that PPAI and PP 5 might contribute the homeostasis of fluidity of blood in the placenta.
- 一般社団法人 日本血栓止血学会の論文
一般社団法人 日本血栓止血学会 | 論文
- 日本人のＡＤＡＭＴＳ１３
- Infection of specific strains of Streptococcus mutans exacerbated intracerebral hemorrhage
- Transcriptional regulation of megakaryopoiesis and thrombopoiesis
- 新規血小板活性化受容体ＣＬＥＣ－２ その発見から今後の展望まで:その発見から今後の展望まで
- １．臨床血栓止血学オーバービュー